US 12,410,196 B2
Benzopyrimidine compounds and use thereof
Yang Zhang, Shanghai (CN); Wentao Wu, Shanghai (CN); Kaijun Geng, Shanghai (CN); Jikui Sun, Shanghai (CN); Yangyang Xu, Shanghai (CN); Jian Li, Shanghai (CN); and Shuhui Chen, Shanghai (CN)
Filed by USYNOVA PHARMACEUTICALS LTD., Shanghai (CN)
Filed on Jul. 10, 2024, as Appl. No. 18/768,367.
Application 18/768,367 is a continuation of application No. PCT/CN2023/073182, filed on Jan. 19, 2023.
Claims priority of application No. 202210072243 (CN), filed on Jan. 21, 2022; application No. 202210113080 (CN), filed on Jan. 29, 2022; application No. PCT/CN2022/075732 (WO), filed on Feb. 9, 2022; application No. 202210239568 (CN), filed on Mar. 11, 2022; application No. 202210693538 (CN), filed on Jun. 17, 2022; application No. 202210837790 (CN), filed on Jul. 15, 2022; and application No. 202210989455 (CN), filed on Aug. 17, 2022.
Prior Publication US 2024/0383924 A1, Nov. 21, 2024
Int. Cl. C07D 519/00 (2006.01); A61K 31/517 (2006.01); A61P 35/00 (2006.01)
CPC C07D 519/00 (2013.01) [A61K 31/517 (2013.01); A61P 35/00 (2018.01)] 14 Claims
 
1. A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

OG Complex Work Unit Chemistry